Get the Daily Brief
Latest Biotech News
Quantum Advances: DNA-Based Neural Networks and Long-Range Entanglement
Pioneering studies at Caltech and other institutions have demonstrated DNA molecules programmed to function as supervised neural networks, representing a novel direction for molecular computing...
Treeline Biosciences Unveils First Clinical Candidates With Over $1 Billion Funding
Treeline Biosciences, a Massachusetts-based biotech startup, has revealed details of its pipeline including three cancer drug candidates entering clinical testing. The company has raised over $1.1...
FDA Accepts First Biosimilar Without Clinical Efficacy Studies, Pioneered by Professor Niazi
Professor Sarfaraz K. Niazi has secured a historic regulatory milestone with the FDA’s acceptance of a biosimilar application without requiring clinical efficacy studies (CESs). This breakthrough,...
Positive Phase 3 Results Boost Ionis’ Olezarsen as Leading Therapy for Severe Hypertriglyceridemia
Ionis Pharmaceuticals reported positive topline outcomes from two pivotal Phase 3 studies (CORE and CORE2) of olezarsen, targeting severe hypertriglyceridemia (sHTG). The therapy achieved up to...
Novartis and Arrowhead Extend Collaboration With $200M Upfront for Parkinson’s RNAi Therapy
Novartis has entered a significant licensing and collaboration agreement with Arrowhead Pharmaceuticals, investing $200 million upfront for rights to ARO-SNCA, a preclinical siRNA therapy...
Mercy BioAnalytics Secures $59M Series B to Launch Ovarian Cancer Blood Test in 2026
Mercy BioAnalytics, a cancer early detection firm based in Waltham, Massachusetts, closed a $59 million Series B to fund commercialization of its blood-based ovarian cancer screening test slated...
Comprehensive Brain-Wide Neural Activity Maps Reveal Distributed Decision-Making Networks
The International Brain Laboratory published the first full brain-wide single-neuron activity map during decision-making behavior in mice, recording over 500,000 neurons across 279 brain areas and...
Amgen Commits $600 Million to Advanced Science and Innovation Center in California
Amgen announced plans to invest over $600 million to construct a new state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The facility will...
DNA-Based Neural Networks Demonstrate Supervised Learning Capabilities
Caltech researchers have engineered a neural network constructed from DNA strands, marking a leap in biochemical computing. Unlike electronic neural networks, this DNA-based system performs...
AI-Driven Virtual Cell Models Propel Cancer Research and Drug Development
Researchers led by Yang, T. and Wang, YY have unveiled an artificial intelligence approach that creates virtual cell models simulating intricate human cellular behaviors. These models enable...
Novartis Upfronts $200M for Arrowhead RNAi Parkinson’s Candidate
Novartis has entered a significant licensing and collaboration agreement with Arrowhead Pharmaceuticals, investing $200 million upfront to develop Arrowhead's preclinical siRNA therapy targeting...
Ionis’ Olezarsen Cuts Triglycerides, Acute Pancreatitis in Severe Hypertriglyceridemia
Ionis Pharmaceuticals announced positive results from two pivotal Phase 3 trials demonstrating that olezarsen markedly reduced fasting triglycerides by up to 72% and decreased acute pancreatitis...
Amgen Commits $600 Million to New California Science and Innovation Center
Amgen has announced plans to invest over $600 million to build a state-of-the-art center for science and innovation at its Thousand Oaks global headquarters. The facility will consolidate...
Treeline Biosciences Discloses $200M Round, Names First Clinical Candidates
Treeline Biosciences announced a $200 million series A extension, totaling $1.1 billion raised to date, alongside unveiling its first three clinical-stage oncology candidates. The company’s...
Fiber-seq Multiomics Assay Reagents Comarketed by PacBio and EpiCypher
Pacific Biosciences and EpiCypher have entered a comarketing agreement for the Cutana Hia5 methyltransferase enzyme, a key reagent in the Fiber-seq assay. Fiber-seq leverages enzymatic DNA...
NeoGenomics Wins Patent Suit, Advances Radar MRD Commercialization
NeoGenomics achieved a key legal victory as the Middle District of North Carolina invalidated Natera’s patents underpinning its Signatera assay, enabling NeoGenomics to resume commercialization of...
Novel Protein Therapeutic 'Crunch' Reprograms Immune Clearance of Harmful Cells
Kyoto University researchers have engineered a synthetic protein named Crunch that reprograms the phagocytic immune system to selectively eliminate living harmful cells, such as cancer or...
Mercy BioAnalytics Raises $59M to Commercialize Early Cancer Detection Tests
Mercy BioAnalytics secured $59 million in Series B funding to advance commercialization of its blood-based ovarian cancer test panel that detects tumor-specific proteins on extracellular vesicles....
Upstream Bio Posts Phase 2 Win in Sinusitis Amid Market Skepticism
Upstream Bio announced positive Phase 2 data for its candidate verekitug in sinusitis treatment, meeting study endpoints. Despite this clinical success, investor enthusiasm has been muted due to a...
FDA Regulatory Updates and Clinical Trial Approvals for Early September 2025
Recent regulatory developments include approvals, designations, and submissions for various drugs and medical devices spanning oncology, infectious diseases, and diagnostics. Noteworthy actions...